Innate immune sensors, such as Toll-like receptor 2 (TLR2), are overexpressed in bone marrow CD34+ cells from LR-MDS patients and gain of function mutations correlate with progression. The gene discussed is TLR2; the disease is myelodysplastic syndrome.